A murine model of granulomatous colitis with mesenteric lymphadenitis induced by mycobacterial cord factor

Virchows Archiv

Volumn 442, Issue 2, 2003, Pages 151-158

  Sogawa, Mitsue ^a   Matsumoto, Takayuki ^a   Yamagami, Hirokazu ^a   Yamada, Tamaki ^b   Ozeki, Yuriko ^a   Yano, Ikuya ^c   Nakajima, Yuji ^a   Arakawa, Tetsuo ^a   Kaneda, Kenji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c Institute of BCG   (Japan)

Author keywords

Cord factor; Granulomatous colitis; Lymphadenitis; Rodents

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CORD FACTOR; CYTOKINE; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTEROCOLITIS; INTESTINE EPITHELIUM; INTESTINE ULCER; LAMINA PROPRIA; LUNG GRANULOMA; LYMPH VESSEL; LYMPHOCYTIC INFILTRATION; LYMPHOID TISSUE; MACROPHAGE; MALE; MESENTERIC LYMPHADENITIS; MESENTERY LYMPH NODE; MYCOBACTERIUM; MYOFIBROBLAST; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; TH1 CELL; TISSUE INJURY;

EID: 0037296476     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-002-0698-6     Document Type: Article

References (42)

1. Aiko S, Grisham MB (1995) Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats. Gastroenterology 109:142-150
2. Akinoglu A, Bilgin I (1988) Tuberculous enteritis and peritonitis. Can J Surg 31:55-58
3. Arnold C, Moradpour D, Blum HE (1998) Tuberculous colitis mimicking Crohn's disease. Am J Gastroenterol 93:2294-2296
4. Berrebi D, Banerjee A, Paris R, Potet F, Aigrain Y, Emilie D, Cezard JP, Hugot JP, Navarro J, Peuchmaur M (1997) In situ Rantes and interferon-gamma gene expression in pediatric small bowel Crohn's disease. J Pediatr Gastroenterol Nutr 25:371-376
5. Camoglio L, te Velde AA, de Boer A, ten Kate FJ, Kopf M, van Deventer SJ (2000) Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice. Eur J Immunol 30:1486-1495
6. Cohavy O, Harth G, Horwitz M, Eggena M, Landers C, Sutton C, Targan SR, Braun J (1999) Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease. Infect Immun 67:6510-6517
7. Fujiwara N, Pan J, Enomoto K, Terano Y, Honda T, Yano I (1999) Production and partial characterization of anti-cord factor (trehalose-6:6′-dimycolate) IgG antibody in rabbits recognizing mycolic acid subclasses of Mycobacterium tuberculosis or Mycobacterium avium. FEMS Immunol Med Microbiol 24:141-149
8. Geboes K, van den Oord J, De Wolf-Peeters C, Desmet V, Rutgeerts P, Janssens J, Vantrappen G, Penninckx F, Kerremans R (1986) The cellular composition of granulomas in mesenteric lymph nodes from patients with Crohn's disease. Virchows Arch A Pathol Anat Histopathol 409:679-692
9. Guillemard E, Geniteau-Legendre M, Kergot G, Lemaire G, Gessani S, Labarre C, Quero AM (1998) Simultaneous production of IFN-gamma, IFN-alpha/beta and nitric oxide in peritoneal macrophages from TDM-treated mice. J Biol Regul Homeost Agents 12:106-111
10. Horvath KD, Whelan RL (1998) Intestinal tuberculosis: return of an old disease. Am J Gastroenterol 93:692-696
11. Hubbard J, Surawics CM (1999) Etiological role of mycobacterium in Crohn's disease: an assessment of the literature. Dig Dis 17:6-13
12. Hulten K, Almashhrawi A, El-Zaatari FA, Graham DY (2000) Antibacterial therapy for Crohn's disease: a review emphasizing therapy directed against mycobacteria. Dig Dis Sci 45:445-456
13. Kakazu T, Hara J, Matsumoto T, Nakamura S, Oshitani N, Arakawa T, Kitano A, Nakatani K, Kinjo F, Kuroki T (1999) Type 1 T-helper cell predominance in granulomas of Crohn's disease. Am J Gastroenterol 94:2149-2155
14. Kaneda K, Sumi Y, Kurano F, Kato Y, Yano I (1986) Granuloma formation and hemopoiesis induced by C36 - 48-mycolic acid-containing glycolipids from Nocardia rubra. Infect Immun 54:869-875
15. Kobayashi K, Brown WR, Brennan PJ, Blaser MJ (1988) Serum antibodies to mycobacterial antigens in active Crohn's disease. Gastroenterology 94:1404-1411
16. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W (1993) Interleukin 10-deficient mice develop chronic enterocolitits. Cell 75:263-274
17. Mathan MM, Gilmour HM, Whitehead R (1995) The large intestine. In: Whitehead R (ed) Gastrointestinal and oesophageal pathology, 2nd edn. Churchill Livingstone, Edinburgh. pp 589-632
18. Matsumoto S, Okabe Y, Setoyama H, Takayama K, Ohtsuka J, Funahashi H, Imaoke A, Okada Y, Umesaki Y (1998) Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut 43:71-78
19. Matsunaga K, Ito M (2000) Quantitative analysis of apoptotic cell death in granulomatous inflammation induced by intravenous challenge with Cryptococcus neoformans and bacillus Calmette-Guérin vaccine. Pathol Int 50:206-218
20. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S (1993) Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75:275-282
21. Mooney EE, Walker J, Hourihane DO (1995) Relation of granulomas to lymphatic vessels in Crohn's disease. J Clin Pathol 48:335-338
22. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795-803
23. Nakatani K, Seki S, Kawada N, Kaneda K (2002) Expression of SPARC (secreted protein, acidic and rich in cysteine osteonectin) by activated hepatic stellate cells and its correlation with the stages of fibrogenesis in human chronic hepatitis. Virchows Arch (in press)
24. Natsuhara Y, Oka S, Kaneda K, Kato Y, Yano I (1990) Parallel antitumor, granuloma-forming and tumor-necrosis-factor-priming activities of mycoloyl glycolipids from Nocardia rubra that differ in carbohydrate moiety: structure-activity relationships. Cancer Immunol Immunother 31:99-106
25. Ogura Y, Bonnen DK, Hanauer SB, Nunez G, Cho JH (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 31:603-606
26. Oswald IP, Dozois CM, Petit J-F, Lemaire G (1997) Interleukin-12 synthesis is a required step in trehalose dimycolate-induced activation of mouse peritoneal macrophages. Infect Immun 65:1364-1369
27. Ozeki Y, Kaneda K, Fujiwara N, Morimoto M, Oka S, Yano I (1997) In vivo induction of apoptosis in the thymus by administration of mycobacterial cord factor (trehalose 6:6′-dimycolate). Infect Immun 65:1793-1799
28. Palnaes-Hanson C, Hegnhoj J, Moller A, Brauer C, Hage E, Jarnum S (1990) Ulcerative colitis and Crohn's disease of the colon: is there a macroscopic difference? Ann Chir Gynaecol 79:78-81
29. Pan J, Fujiwara N, Oka S, Maekura R, Ogura T, Yano I (1999) Anti-cord factor (trehalose 6:6′-dimycolate) IgG antibody in tuberculosis patients recognizes mycolic acid subclasses. Microbiol Immunol 43:863-869
30. Price AB (1978) Overlap in the spectrum of non-specific inflammatory bowel disease - 'colitis indeterminate'. J Clin Pathol 31:567-577
31. Pulimood AB, Ramakrishna BS, Kurian G, Peter S, Patra S, Mathan VI, Mathan MM (1999) Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn's disease from tuberculosis. Gut 45:537-541
32. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253-261
33. Sakaguchi I, Ikeda N, Nakayama M, Kato Y, Yano I, Kaneda K (2000) Trehalose 6:6′-dimycolate (cord factor) enhances neovascularization through vascular endothelial growth factor production by neutrophils and macrophages. Infect Immun 68:2043-2052
34. Sartor RB, Cromartie WJ, Powell DW, Schwab JH (1985) Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology 89:587-595
35. Sheehan AL, Warren BF, Gear MWL, Shepherd NA (1992) Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br J Surg 79:955-958
36. Tsuji H, Mukaida N, Harada A, Kaneko S, Matsushita E, Nakanuma Y. Tsutsui H, Okamura H, Nakanishi K, Tagawa Y, Iwakura Y, Kobayashi K, Matsushima T (1999) Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-gamma-deficient mice by a concomitant reduction of TNF-alpha, IL-12, and IL-18 production. J Immunol 162:1049-1055
37. Watanabe M, Takaishi H, Hosoda Y, Ezaki T, Yajima T, Inoue N, Ueno Y, Iwao Y, Ishii H, Ishikawa H, et al (1995) CD4+ intestinal mucosal lymphocytes in the pathogenesis of Crohn's disease. J Gastroenterol 30 Supp18:73-75
38. Wyatt J, Oberhuber G, Pongratz S, Puspok A, Moser G, Novacek G, Lochs H, Vogelsang H (1997) Increased gastric and intestinal permeability in patients with Crohn's disease. Am J Gastroenterol 92:1891-1896
39. Yamada T, Sartor RB, Marshall S, Specian RD, Grisham MB (1993) Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats. Gastroenterology 104:759-771
40. Yamagami H, Matsumoto T, Fujiwara N, Arakawa T, Kaneda K, Yano I, Kobayashi K (2001) Trehalose 6:6′-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivity-type granulomas in mice. Infect Immun 69:810-815
41. Yano I, Tomiyasu I, Kitabatake S, Kaneda K (1984) Granuloma forming activity of mycolic acid-containing glycolipids in nocardia and related taxa. Acta Leprol 2:341-349
42. Yano I, Oka S, Natsuhara Y, Kato Y, Tomiyasu I, Kaneda K (1988) Molecular structure and immunopharmacological activities of the new glycolipids containing mycolic acids in actinomycetales. In: Okami Y, Beppu T, Ogawara H (eds) Biology of actinomycetes. Japan Scientific Societies, Tokyo, pp 469-477